Clinical Trials Insight: 700024039
Latest Information Update: 31 Jul 2024
Price :
$35 *
At a glance
- Drugs Bafetinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors INNOVIVE Pharmaceuticals
- 22 Jun 2007 New trial record.